TECPR2 and Riley-Day syndrome: Mutations in TECPR2 leading to the translation of a truncated and unstable version of TECPR2 cause a form of HSP (Oz-Levi et al., 2012) and hereditary sensory and autonomic neuropathy (HSAN-III) (Heimer et al., 2016).